Dr. Ghosh on the Future of CAR T-Cell Therapy in Patients With Hematologic Malignancies – OncLive
OncLive |
Dr. Ghosh on the Future of CAR T-Cell Therapy in Patients With Hematologic Malignancies
OncLive Nilanjan Ghosh, MD, PhD, physician, Levine Cancer Institute, discusses the future of chimeric antigen receptor (CAR) T-cell therapy in the treatment of patients with hematologic malignancies. There are many unanswered questions with regard to CAR T … |
